Population pharmacokinetics of TC-5214, a nicotinic channel modulator, in phase I and II clinical studies

Prediction-Corrected Visual Predictive Checks for Diagnosing Nonlinear Mixed-Effects Models

(2011) Martin Bergstrand et al.   AAPS Journal

Essential Pharmacokinetic Information for Drug Dosage Decisions: A Concise Visual Presentation in the Drug Label

(2011) D Menon-Andersen et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Standardized Visual Predictive Check Versus Visual Predictive Check for Model Evaluation

(2011) Diane D. Wang et al.   JOURNAL OF CLINICAL PHARMACOLOGY

P.2.a.002 The potential of the nicotinic channel blocker tc-5214 as augmentation treatment in patients with major depression

(2010) G. Dunbar et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Mecamylamine – a nicotinic acetylcholine receptor antagonist with potential for the treatment of neuropsychiatric disorders

(2009) Ingrid Bacher et al.   EXPERT OPINION ON PHARMACOTHERAPY

TC-5214 (S-(+)-Mecamylamine): A Neuronal Nicotinic Receptor Modulator with Antidepressant Activity

(2008) Patrick M. Lippiello et al.   CNS Neuroscience & Therapeutics